American Association for Cancer Research Annual Meeting

Healio.com brings you the highlights from the American Association for Cancer Research Annual Meeting. Refer back to this page often to read the latest news from AACR, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Meeting News

Durvalumab-tremelimumab combination shows antitumor activity in urothelial cancer

April 17, 2018
The combination of durvalumab and tremelimumab demonstrated antitumor activity among patients with urothelial cancer, according to study results…
Meeting News

Nivolumab confers significant OS benefit in recurrent or metastatic head and neck squamous cell carcinoma

April 16, 2018
CHICAGO — Nivolumab continued to confer a significant OS benefit compared with investigator’s choice of therapy among patients with…
Meeting News

NCI director: Basic science, big data among key areas of opportunity

April 16, 2018
CHICAGO — The director of NCI has identified four “areas of particular opportunity” on which he intends to focus during his…
Meeting NewsPerspective

Atezolizumab plus chemotherapy improves PFS in non-small cell lung cancer

April 16, 2018
CHICAGO — The addition of atezolizumab to bevacizumab plus chemotherapy extended PFS for patients with non-small cell lung cancer, according to…
Meeting News

Tumor mutational burden feasible biomarker for benefit from dual checkpoint inhibition

April 16, 2018
CHICAGO — Higher tumor mutational burden appeared associated with greater response to treatment with nivolumab plus ipilimumab among patients…
Meeting NewsPerspective

Neoadjuvant nivolumab induces pathologic responses in advanced resectable non-small cell lung cancer

April 16, 2018
CHICAGO — Neoadjuvant therapy with the anti-PD-1 therapy nivolumab induced responses among nearly half of patients with resectable lung cancer…
Meeting News

Immunotherapy superior to chemotherapy for advanced lung cancer with high tumor mutational burden

April 16, 2018
CHICAGO — Immunotherapy with nivolumab plus ipilimumab significantly prolonged PFS compared with standard chemotherapy among patients with…
Meeting NewsPerspective

Immunotherapy-chemotherapy combination extends survival in newly diagnosed metastatic lung cancer

April 16, 2018
CHICAGO — The addition of the anti-PD-1 therapy pembrolizumab to chemotherapy significantly improved outcomes among patients with newly…

American Association for Cancer Research presents special recognition awards

April 16, 2018
The American Association for Cancer Research will present special recognition awards to four individuals whose work has made extraordinary…
Meeting News

Abemaciclib effective as initial therapy for certain women with advanced breast cancer

April 15, 2018
CHICAGO — The addition of abemaciclib to initial treatment with a nonsteroidal aromatase inhibitor appeared effective for women with hormone…